nach oben

Neuroradiology

Erschienen in:

01.09.2010 | Topic Article

Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma

verfasst von: Vincent Vandecaveye, Frederik De Keyzer, Piet Dirix, Maarten Lambrecht, Sandra Nuyts, Robert Hermans

Erschienen in: Neuroradiology | Ausgabe 9/2010

Einloggen, um Zugang zu erhalten

Abstract

In the head and neck, squamous cell carcinoma is one of the most common tumour types. Currently, the primary imaging modalities for initial locoregional staging are computed tomography and—to a lesser extent—magnetic resonance imaging, whilst [¹⁸F]fluorodeoxyglucose (FDG) positron emission tomography has additional value in the detection of subcentimetric metastatic lymph nodes and of tumour recurrence after chemoradiotherapy (CRT). However, dependency on the morphological and size-related criteria of anatomical imaging and the limited spatial resolution and FDG avidity of inflammation in metabolic imaging may reduce diagnostic accuracy in the head and neck. Diffusion-weighted magnetic resonance imaging (DWI) is a noninvasive imaging technique that measures the differences in water mobility in different tissue microstructures. Water mobility is likely influenced by cell size, density, and cellular membrane integrity and is quantified by means of the apparent diffusion coefficient. As such, the technique is able to differentiate tumoural tissue from normal tissue, inflammatory tissue and necrosis. In this article, we examine the use of DWI in head and neck cancer, focussing on technique optimization and image interpretation. Afterwards, the value of DWI will be outlined for clinical questions regarding nodal staging, lesion characterization, differentiation of post-CRT tumour recurrence from necrosis and inflammation, and predictive imaging towards treatment outcome. The possible consequences of adding DWI towards therapeutic management are outlined.

Ang KK, Harris J, Garden AS et al (2005) Concomitant boost radiation plus concurrent cisplatinum for advanced head and neck carcinomas: radiation Therapy Oncology Group phase II trial 99-14. J Clin Oncol 23:3008–3015CrossRefPubMed

Kaanders JH, Pop LA, Marres HA et al (2002) ARCON: experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 52:769–778CrossRefPubMed

El-Deiry M, Funk GF, Nalwa S et al (2005) Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg 13:879–885CrossRef

Castelijns JA, van den Brekel MW (2002) Imaging of lymphadenopathy in the neck. Eur Radiol 12:727–738CrossRefPubMed

Zbären P, Caversaccio M, Thoeny HC, Nuyens M, Curschmann J, Stauffer E (2006) Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg 135:838–843CrossRefPubMed

Ng SH, Yen TC, Chang JT et al (2006) Prospective study of [¹⁸F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 24:4371–4376CrossRefPubMed

McCollum AD, Burrell SC, Haddad RI et al (2004) Positron emission tomography with ¹⁸F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26:890–896CrossRefPubMed

Ross BD, Moffat A, Lawrence TS et al (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer 2:581–587

Yoshikawa K, Nakata Y, Yamada K, Nakagawa M (2004) Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 75:481–484CrossRefPubMed

10.

Eastwood JD, Lev MH, Wintermark M et al (2003) Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. Am J Neuroradiol 24:1869–1875PubMed

11.

Wang J, Takashima S, Takayama F et al (2001) Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 220:621–630CrossRefPubMed

12.

Le Bihan D, Breton E, Lallemand D, Aubin ML et al (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505PubMed

13.

Melhem ER, Itoh R, Jones L et al (2000) Diffusion tensor imaging of the brain: effect of diffusion weighting on trace and anisotropy measurements. Am J Neuroradiol 21:1813–1820PubMed

14.

Thoeny HC, De Keyzer F, Vandecaveye V et al (2005) Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 237:492–499CrossRefPubMed

15.

Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Neuroradiol 188:1622–1635

16.

Vandecaveye V, De Keyzer F, Hermans R (2008) Diffusion-weighted magnetic resonance imaging in neck lymph adenopathy. Cancer Imaging 30:173–180CrossRef

17.

De Foer B, Vercruysse JP, Bernaerts A et al (2008) Detection of postoperative residual cholesteatoma with non-echo-planar diffusion-weighted magnetic resonance imaging. Otol Neurotol 29:513–517CrossRefPubMed

18.

Srinivasan A, Dvorak R, Perni K, Rohrer S, Mukherji SK (2008) Differentiation of benign and malignant pathology in the head and neck using 3 T apparent diffusion coefficient values: early experience. Am J Neuroradiol 29:40–44CrossRefPubMed

19.

Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102–125PubMed

20.

Sun X, Wang H, Chen F et al (2009) Diffusion-weighted MRI of hepatic tumor in rats: comparison between in vivo and postmortem imaging acquisitions. J Magn Reson Imaging 29:621–628CrossRefPubMed

21.

Roth Y, Tichler T, Kostenich G et al (2004) High-b-value diffusion-weighted MR-imaging for pre-treatment prediction and early monitoring of tumor response to therapy in mice. Radiology 232:685–692CrossRefPubMed

22.

Le Bihan D, Breton E, Lallemand D et al (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505PubMed

23.

Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M (2004) Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22:275–282PubMed

24.

Vandecaveye V, De Keyzer F, Nuyts S et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971PubMed

25.

Vandecaveye V, Dirix P, De Keyzer F et al (2010) Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 20:1703–1714CrossRefPubMed

26.

Sibon I, Ménégon P, Orgogozo JM et al (2009) Inter- and intraobserver reliability of five MRI sequences in the evaluation of the final volume of cerebral infarct. J Magn Reson Imaging 29:1280–1284CrossRefPubMed

27.

De Bondt RB, Hoeberigs MC, Nelemans PJ et al (2009) Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 51:183–192CrossRefPubMed

28.

Vandecaveye V, De Keyzer F, Vander Poorten V et al (2009) Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 251:134–146CrossRefPubMed

29.

Perrone A, Guerrisi L, Izzo L, et al (2009) Diffusion-weighted MRI in cervical lymph nodes: Differentiation between benign and malignant lesions. Eur J Radiol. doi:10.1016/j.ejrad.2009.07.039

30.

Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J (2009) Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 72:381–387CrossRefPubMed

31.

Kim S, Loevner L, Ouon H et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15:986–994CrossRefPubMed

32.

Abdel Razek AA, Kandeel AY, Soliman N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. Am J Neuroradiol 28:1146–1152CrossRefPubMed

33.

King AD, Ahuja AT, Yeung DK et al (2007) Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 245:806–813CrossRefPubMed

34.

Razek A, Soliman N, Elkhamary S, Alsharaway M, Tawfik A (2006) Role of diffusion-weighted MR imaging in cervical adenopathy. Eur Radiol 16:1468–1477CrossRefPubMed

35.

Sumi M, van Sakihama N, Sumi T et al (2003) Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 24:1627–1634PubMed

36.

Maeda M, Kato H, Sakuma H, Maier SE, Takeda K (2005) Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. Am J Neuroradiol 26:1186–1192PubMed

37.

Sumi M, Van Cauteren M, Nakamura T (2006) MR microimaginig of benign and malignant nodes in the neck. Am J Roentgenol 186:749–757CrossRef

38.

King AD, Tse GM, Ahuja AT et al (2004) Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging and US. Radiology 230:720–726CrossRefPubMed

39.

Muenzel D, Duetsch S, Fauser C et al (2009) Diffusion-weighted magnetic resonance imaging in cervical lymphadenopathy: report of three cases of patients with Bartonella henselae infection mimicking malignant disease. Acta Radiol 50:914–916CrossRefPubMed

40.

Suoglo Y, Erdamar B, Katircioglu OS, Karatay MC, Sunay T (2002) Extracapsular spread in ipsilateral and contralateral neck metastases in laryngeal cancer. Ann Otol Rhinol Laryngol 111:447–454

41.

Capote A, Escorial V, Munoz-Guerra MF, Rodriguez-Campo FJ, Gamallo C, Vanal L (2007) Elective neck dissection in early stage oral squamous cell carcinoma—does it influence recurrence and survival? Head Neck 29:3–11CrossRefPubMed

42.

Dirix P, Vandecaveye V, De Keyzer F et al (2009) Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning. Int J Radiat Oncol Biol Phys 76:761–766PubMed

43.

Gregoire V, Coche E, Cosnard G, Hamoir M, Reychler H (2000) Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56:135–150CrossRefPubMed

44.

Kagei K, Shirato H, Nishioka T et al (2000) Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol 54:117–121CrossRefPubMed

45.

Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van den Bogaert W (2004) Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 72:119–127CrossRefPubMed

46.

Kato H, Kanematsu M, Tanaka O et al (2009) Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol 19:103–109CrossRefPubMed

47.

Galbán CJ, Mukherji SK, Chenevert TL et al (2009) A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 18:184–190

48.

Brizel DM, Prosnitz RG, Hunter S et al (2004) Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 58:1418–1423CrossRefPubMed

49.

Machtay M, Moughan J, Trotti A et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:2582–2589CrossRef

50.

Yom SS, Machtay M, Biel MA et al (2005) Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol 28:385–392CrossRefPubMed

Titel: Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma
verfasst von: Vincent Vandecaveye
Frederik De Keyzer
Piet Dirix
Maarten Lambrecht
Sandra Nuyts
Robert Hermans
Publikationsdatum: 01.09.2010
Verlag: Springer-Verlag
Erschienen in: Neuroradiology / Ausgabe 9/2010
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI: https://doi.org/10.1007/s00234-010-0743-0

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2010

In vitro evaluation of the sinus sagittalis superior thrombosis model in the rat using 3D micro- and nanocomputed tomography

Intra-arterial colforsin daropate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

In vitro comparison of different carotid artery stents: a pixel-by-pixel analysis using CT angiography and contrast-enhanced MR angiography at 1.5 and 3 T

European Society of Neuroradiology (ESNR)

Foreword